266 related articles for article (PubMed ID: 28424411)
1. Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.
Memmel S; Sisario D; Zöller C; Fiedler V; Katzer A; Heiden R; Becker N; Eing L; Ferreira FLR; Zimmermann H; Sauer M; Flentje M; Sukhorukov VL; Djuzenova CS
Oncotarget; 2017 Jul; 8(28):45298-45310. PubMed ID: 28424411
[TBL] [Abstract][Full Text] [Related]
2. Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.
Djuzenova CS; Fiedler V; Katzer A; Michel K; Deckert S; Zimmermann H; Sukhorukov VL; Flentje M
Oncotarget; 2016 Jun; 7(25):38191-38209. PubMed ID: 27224913
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL
BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines.
Hartmann S; Günther N; Biehl M; Katzer A; Kuger S; Worschech E; Sukhorukov VL; Krohne G; Zimmermann H; Flentje M; Djuzenova CS
Cancer Lett; 2013 May; 331(2):200-10. PubMed ID: 23340178
[TBL] [Abstract][Full Text] [Related]
5. Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status.
Djuzenova CS; Fiedler V; Memmel S; Katzer A; Hartmann S; Krohne G; Zimmermann H; Scholz CJ; Polat B; Flentje M; Sukhorukov VL
Exp Cell Res; 2015 Jan; 330(2):346-357. PubMed ID: 25149900
[TBL] [Abstract][Full Text] [Related]
6. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
Ströbele S; Schneider M; Schneele L; Siegelin MD; Nonnenmacher L; Zhou S; Karpel-Massler G; Westhoff MA; Halatsch ME; Debatin KM
PLoS One; 2015; 10(6):e0131670. PubMed ID: 26121251
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
Chen MH; Chiang KC; Cheng CT; Huang SC; Chen YY; Chen TW; Yeh TS; Jan YY; Wang HM; Weng JJ; Chang PM; Liu CY; Li CP; Chao Y; Chen MH; Huang CY; Yeh CN
Oncotarget; 2014 May; 5(9):2372-89. PubMed ID: 24796583
[TBL] [Abstract][Full Text] [Related]
8. Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.
Memmel S; Sukhorukov VL; Höring M; Westerling K; Fiedler V; Katzer A; Krohne G; Flentje M; Djuzenova CS
PLoS One; 2014; 9(1):e87052. PubMed ID: 24498019
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.
Djuzenova CS; Fischer T; Katzer A; Sisario D; Korsa T; Steussloff G; Sukhorukov VL; Flentje M
BMC Cancer; 2021 Nov; 21(1):1201. PubMed ID: 34763650
[TBL] [Abstract][Full Text] [Related]
10. FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.
Firat E; Niedermann G
Oncotarget; 2016 Aug; 7(34):54883-54896. PubMed ID: 27448972
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
[TBL] [Abstract][Full Text] [Related]
12. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
Walsby EJ; Lazenby M; Pepper CJ; Knapper S; Burnett AK
Br J Haematol; 2013 Apr; 161(1):57-67. PubMed ID: 23356405
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.
Hayashi K; Michiue H; Yamada H; Takata K; Nakayama H; Wei FY; Fujimura A; Tazawa H; Asai A; Ogo N; Miyachi H; Nishiki T; Tomizawa K; Takei K; Matsui H
Sci Rep; 2016 Mar; 6():23372. PubMed ID: 26988603
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
15. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
16. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
Miekus K; Kijowski J; Sekuła M; Majka M
Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
[TBL] [Abstract][Full Text] [Related]
17. Significance of filamin A in mTORC2 function in glioblastoma.
Chantaravisoot N; Wongkongkathep P; Loo JA; Mischel PS; Tamanoi F
Mol Cancer; 2015 Jul; 14():127. PubMed ID: 26134617
[TBL] [Abstract][Full Text] [Related]
18. Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia.
Djuzenova CS; Blassl C; Roloff K; Kuger S; Katzer A; Niewidok N; Günther N; Polat B; Sukhorukov VL; Flentje M
Cancer Biol Ther; 2012 Apr; 13(6):425-34. PubMed ID: 22286776
[TBL] [Abstract][Full Text] [Related]
19. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
20. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
